Abstract Background: Diabetes mellitus (DM) is a metabolic disorder associated with cognitive impairment
Coverage requirements depend on why your healthcare provider has prescribed Wegovy, but common criteria include a higher body mass index (BMI), a reduced-calorie diet, and increased physical activity
A person with a history of MTC, a patient with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a patient with a prior serious allergic reaction to semaglutide GLP-1s ingredients, or someone who has had pancreatitis should not take Mounjaro (tirzepatide)
Cases involving gastrointestinal harms will remain with MDL 3094
Oral semaglutide requires fasting administration (no food or drink except water for 30 minutes before and after the dose) and has higher gastrointestinal side-effect rates than injections because the drug saturates the gastric mucosa
These medications work by mimicking natural hormones that regulate appetite and blood sugar levels, slowing gastric emptying and promoting feelings of fullness